If AMPK activity is stimulated with metformin, SREBP-1c cleavage and nuclear translocation (via ser 372 phosphorylation) are suppressed, leading to attenuation of liver steatosis in mice deficient in low-density lipoprotein (LDL) with diet-induced insulin resistance [35]. The gene discussed is SREBF1; the disease is Hepatic steatosis.